Andreas Loos

Utility of the <scp>P</scp>19 suppressor of gene‐silencing protein for production of therapeutic antibodies in <i><scp>N</scp>icotiana</i> expression hosts

Freydoun Garabagi, Erin Gilbert, Andreas Loos et al. · Plant Biotechnology Journal · 2012 · 115 citations · Full text

Expression and glycoengineering of functionally active heteromultimeric IgM in plants

Andreas Loos, Clemens Grünwald‐Gruber, Friedrich Altmann et al. · Proceedings of the National Academy of Sciences · 2014 · 79 citations · Full text

Plant Physiology, Molecular Pharming, Glycobiology +19

Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters

Michael S. Piepenbrink, Jun‐Gyu Park, Fatai S. Oladunni et al. · Cell Reports Medicine · 2021 · 72 citations · Full text

The human anti‐HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: Down‐regulation of endogenous serine and cysteine proteinase activities could improve antibody production in plant‐based expression platforms

Melanie Niemer, Ulrich Mehofer, Juan Antonio Torres Acosta et al. · Biotechnology Journal · 2014 · 69 citations · Full text

Structural and functional characterization of an anti‐West Nile virus monoclonal antibody and its single‐chain variant produced in glycoengineered plants

Huafang Lai, Junyun He, Jonathan Hurtado et al. · Plant Biotechnology Journal · 2014 · 63 citations · Full text

Single‐chain Variant, Synthetic Virology, Glycobiology +19